戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 h Salmonella enterica serovar Typhimurium (S Typhimurium).
2 erichia coli and Salmonella enterica serovar Typhimurium).
3 hila, Pseudomonas aeruginosa, and Salmonella typhimurium.
4 ty of Zur, ZntR, RcnR and FrmR in Salmonella Typhimurium.
5 e model pathogen Salmonella enterica serovar Typhimurium.
6 bic expansion of Salmonella enterica serovar Typhimurium.
7 ompared to that of the nontyphoidal serovarS Typhimurium.
8 including in the enteric pathogen Salmonella typhimurium.
9 ainst the drug-resistant bacteria Salmonella typhimurium.
10 munoassay of Escherichia coli and Salmonella typhimurium.
11  serotypes Enteritidis, Javiana, Panama, and Typhimurium.
12 n and exhibit increased susceptibility to S. Typhimurium.
13 l biosensor suitable for the detection of S. Typhimurium.
14 know the concentration of serovar Salmonella typhimurium.
15 oducing Klebsiella pneumoniae and Salmonella typhimurium.
16 ic separation (IMS) for detecting Salmonella typhimurium.
17 enzae, and Salmonella enterica serovar Typhi/Typhimurium.
18 ing infection withSalmonella entericaserovar Typhimurium.
19 ) compared to infections with S. Hadar or S. Typhimurium.
20 ellular pathogen Salmonella enterica serovar Typhimurium.
21 thogens, Francisella novicida and Salmonella typhimurium.
22 iving MET-1 or control, then gavaged with S. typhimurium.
23 ed at significantly lowers levels than in S. Typhimurium.
24 gen-CRM197 glycoconjugate vaccine against S. Typhimurium.
25  Enteritidis and 152 (43.3%) were Salmonella Typhimurium.
26 mucosa of mice infected with DsRed-labeled S typhimurium.
27 nvasive pathogen Salmonella enterica serovar Typhimurium.
28 ared with enterocolitis-causing strains of S Typhimurium.
29 s from Salmonella Choleraesuis in Salmonella Typhimurium.
30 particularly E. coli and Salmonella enterica Typhimurium.
31 t conducive to the intracellular growth of S Typhimurium.
32 s with the intracellular pathogen Salmonella typhimurium.
33 om primary human monocytes in response to S. typhimurium.
34 s, 40% (41) were Salmonella enterica serovar Typhimurium, 10% (10) were Salmonella enterica serovar E
35 5 toxin encoded by the broad-host Salmonella Typhimurium (15) .
36 other foodborne pathogens such as Salmonella Typhimurium, (7%) Listeria monocytogenes (3%) and Escher
37        FrmR from Salmonella enterica serovar typhimurium (a CsoR/RcnR-like transcriptional de-repress
38                                              Typhimurium), a common cause of food-borne gastroenterit
39 olated at higher frequencies than Salmonella Typhimurium, a common cause of human illness.
40 uccumb to systemic infection with Salmonella Typhimurium, a pathogenic bacterium that multiplies with
41                        To directly detect S. typhimurium after IMS, a sandwich immunoassay was implem
42                                              Typhimurium, allowing the bacteria to compete with the m
43 6.1%), of which 8017 (79.1%) were Salmonella Typhimurium and 1608 (15.8%) were Salmonella Enteritidis
44      A majority (88/114 [77%]) of Salmonella Typhimurium and 30% (24/79) of Salmonella Enteritidis is
45  in S. Paratyphi A that does not occur in S. Typhimurium and demonstrate curious distinctions in moti
46  periplasmic globular domain of PbgA from S. typhimurium and E. coli, which revealed that the globula
47 ), particularly Salmonella enterica serovars Typhimurium and Enteritidis, is responsible for a major
48                                In Salmonella typhimurium and Escherichia coli, the virulence determin
49 ers, produced by Salmonella enterica serovar Typhimurium and Escherichia coli.
50 8 in response to NLRC4 activators Salmonella Typhimurium and flagellin, canonical or non-canonical NL
51 neficial to the host during infection with S Typhimurium and possibly other enteric pathogens.
52 seal and cattle populations and that both S. Typhimurium and S.
53 neumophila and three CFU per reaction for S. typhimurium and S. aureus.
54            We evaluated the capacities of S. Typhimurium and Salmonella enterica serovar Enteritidis
55 esting Shigella, Salmonella spp., Salmonella typhimurium and Staphylococcus aureus on E. coli specifi
56 ylation by cytosolic flagellin of Salmonella Typhimurium and Yersinia enterocolitica.
57 s that use T3SS, Salmonella enterica serovar Typhimurium and Yersinia pseudotuberculosis.
58 o flagellins from Salmonella typhimurium (S. typhimurium) and Bacillus subtilis (B. subtilis) were ex
59 y modified nonhalotolerant cells (Salmonella typhimurium) and dead vs. live differentiation of nonhal
60                                              Typhimurium)] and two extracellular (Vibrio cholerae and
61 intestinalis, Ruminococcus obeum, Salmonella typhimurium, and Clostridium difficile) to quantify, exp
62 endai are all noticeably less motile than S. Typhimurium, and comparative transcriptome sequencing (R
63  in vitro grown S. Typhi, S. Paratyphi A, S. Typhimurium, and E. coli were used to confirm the specif
64 rial pathogens (Escherichia coli, Salmonella typhimurium, and methicillin-resistant Staphylococcus au
65 ng latex beads, Escherichia coli, Salmonella typhimurium, and Mycobacterium tuberculosis in human and
66 etection of model food pathogens, Salmonella typhimurium, and Staphylococcus aureus, in which the flu
67 ane vesicles (OMVs) isolated from Salmonella Typhimurium are potentially useful for developing subuni
68 3SS and fT3SS of Salmonella enterica serovar Typhimurium at ~5 and ~4 nm resolution using electron cr
69 ecies, Pseudomonas putida KT2440, Salmonella Typhimurium ATCC 14028, Staphylococcus epidermidis ATCC
70 ected epithelial cells, a subpopulation of S Typhimurium bacteria damage their internalization vacuol
71  viral nanocontainer based on the Salmonella typhimurium bacteriophage P22 capsid, genetically incorp
72 ceptible to systemic infection by Salmonella Typhimurium because of loss-of-function mutations in Nra
73 d-borne pathogen Salmonella enterica serovar Typhimurium benefits from acute inflammation in part by
74 njugate vaccines against invasive African S. Typhimurium can have profound effects on immunogenicity
75                  Salmonella enterica serovar Typhimurium can inject effector proteins into host cells
76  Most lineages of the S. enterica subspecies Typhimurium cause gastroenteritis in humans; however, th
77                                   Salmonella Typhimurium causes a self-limiting gastroenteritis that
78      Conversely, Salmonella enterica serovar Typhimurium causes gastroenteritis in humans and thrives
79 llular bacterium Salmonella enterica serovar Typhimurium causes persistent systemic inflammatory dise
80 h as that mediated by l-asparaginase II of S Typhimurium causes suppression of activation-induced T c
81 samples were spiked with standard Salmonella typhimurium cells, and detection was done by measuring t
82                                              Typhimurium chaperone and translocator proteins.
83  ability to kill Salmonella enterica serovar Typhimurium compared to that of macrophages isolated fro
84 T313 pathovar of Salmonella enterica serovar Typhimurium contributes to a high burden of invasive dis
85                            Deletion of the S Typhimurium copper exporters, CopA and GolT, was found t
86 nstrate that the Salmonella enterica serovar Typhimurium core promoter is more active than previously
87                                           S. Typhimurium counters this defense pathway by delivering
88 atory response induced by Salmonella serovar Typhimurium creates a favorable niche for this gut patho
89                              The vaccines S. Typhimurium CVD 1931 and S. Enteritidis CVD 1944 were im
90                                           S. Typhimurium CVD 1931 protected mice against the group B
91 , CVD 1944 did mediate protection against S. Typhimurium D65 (81% efficacy).
92 gesting that cytokinesis failure caused by S Typhimurium delays epithelial cell turnover in the intes
93 introduced into three constructed Salmonella Typhimurium Deltaasd mutants: SLT11 (DeltarfbP), SLT12 (
94  impedimetric aptamer-based biosensor for S. typhimurium detection.
95 ile infection, could also protect against S. typhimurium disease.
96 cles (OMVs) from Salmonella enterica serovar Typhimurium displaying the variable N terminus of PspA (
97 the multidrug-resistant bacterium Salmonella typhimurium DT 104.
98 zation niche for Salmonella enterica serovar Typhimurium during gastrointestinal infections.
99  inoculated Enterococcus spp. and Salmonella typhimurium during the drying of struvite under controll
100                         Though several key S Typhimurium effector genes are missing (e.g., avrA, sopB
101                                              Typhimurium effector, SlrP, prevented anorexia caused by
102 monella enterica subspecies enterica serovar Typhimurium employs a dedicated mechanism, driven by the
103 la pneumoniae or Salmonella enterica serovar Typhimurium, enhanced translocation.
104 al replication, its administration reduced S Typhimurium epithelial cell invasion and lowered the ind
105 orescens, Salmonella Enteritidis, Salmonella Typhimurium, Escherichia coli).
106 r amounts of SPI-1 effector proteins than S. Typhimurium, especially under aerobic growth.
107 tudy showed that Salmonella enterica serovar Typhimurium exhibits sliding motility under magnesium-li
108                  Salmonella enterica serovar Typhimurium exploits the host's type I interferon (IFN-I
109  Enteritidis cases have risen and Salmonella Typhimurium fallen.
110               In Salmonella enterica serovar Typhimurium, flagella-mediated motility is repressed by
111  phosphorylation, whereas deletion of the S. Typhimurium flagellin carboxy-terminus prevented caspase
112 isolated Salmonella, 34.50% was confirmed S. Typhimurium, followed by S. Heidelberg (10.86%) and S. E
113 nd II genes competes poorly with wild-type S Typhimurium for colonization of target tissues.
114 creen mutants of Salmonella enterica serovar Typhimurium for their ability to infect and grow in the
115  the aptamer biosensor could discriminate S. typhimurium from 6 other model bacteria strains.
116                                              Typhimurium from infecting the host.
117 h intraluminal CX3CR1(+) cells preventing S. Typhimurium from infecting the host.
118 to immune serum identified a repertoire of S Typhimurium genes that, when interrupted, result in incr
119                           Mutants of three S Typhimurium genes, STM1461 (ydgT), STM2829 (recA), and S
120                                       The S. Typhimurium genome contains three nitrate reductases, en
121 ore genes within Salmonella enterica serovar Typhimurium genomes reveals a high degree of allelic var
122                        The lower levels of S Typhimurium gut colonization and intestinal inflammation
123 r serovars of Salmonella enterica, Typhi and Typhimurium, have evolved a two-component regulatory sys
124 f a small heat shock protein from Salmonella typhimurium in a dimeric form and two higher oligomeric
125 ublished paper-based detection method for S. typhimurium in bird feces and whole milk.
126  persistence of Salmonella enterica serotype Typhimurium in chickens.
127 ally confirmed by capturing and detecting S. typhimurium in ground chicken and ground beef.
128 sed platform was applied for detection of S. typhimurium in inoculated Starling bird fecal samples an
129  in vitro and increased virulence of serovar Typhimurium in mice.
130 and promote virulence of S. enterica serovar Typhimurium in mice.
131                  However, the response to S. typhimurium in primary human monocytes has not been stud
132 ated its suitability for the detection of S. typhimurium in spiked (1 x 10(2), 1 x 10(4) and 1 x 10(6
133 unosensor was able to specifically detect S. typhimurium in spiked water and juice samples with a sen
134                   The aptasensor detected S. Typhimurium in the concentration range 10(2)-10(8) CFU m
135 required for survival and proliferation of S Typhimurium in the epithelial cell cytosol.
136 ell-dependent opsonophagocytic killing of S. Typhimurium in vitro.
137  ES cell-derived macrophages responded to S. Typhimurium, in a comparable manner to mouse bone marrow
138 SPI-1 expression between S. Paratyphi A andS Typhimurium, indicate that S. Paratyphi A host cell inva
139 at intracellular Salmonella enterica serovar Typhimurium induced the binucleation of a large proporti
140      Additionally, under these conditions S. typhimurium-induced IL-1 release occurred independently
141                                              Typhimurium-induced inflammation is the production of ox
142         The impaired ability to respond to S Typhimurium-induced oxidative stress results in reactive
143 iently attenuate Salmonella enterica serovar Typhimurium-induced pyroptosis and proinflammatory cytok
144  downstream of IFN-I and RIP3 signaling in S Typhimurium-infected macrophages.
145 model of sepsis, we observed that Salmonella typhimurium-infected mice exhibited simultaneous impaire
146 rest due to its high abundance at loci of S. Typhimurium infection and MLN disruption.
147  and host during Salmonella enterica serovar Typhimurium infection and reveal the molecular impact of
148         In this study, we demonstrate that S Typhimurium infection causes IFN-I-mediated up-regulatio
149                                   Salmonella typhimurium infection is reported to activate NLRP3 and
150 ity of disease induced by enteric Salmonella Typhimurium infection is strongly modulated by microbiot
151                  Salmonella enterica serovar Typhimurium infection of immunocompetent mice results in
152                                              Typhimurium infection via Ab.
153                Here, we show that Salmonella Typhimurium infection was accompanied by dysbiosis, decr
154 f2 function and antioxidative responses to S Typhimurium infection, eventually leading to cell death.
155 uppressed during Salmonella enterica serovar Typhimurium infection, facilitating increased IL-1beta p
156                            During Salmonella Typhimurium infection, intestinal CX3CR1(+) cells can ei
157 and function is severely disrupted during S. Typhimurium infection.
158 analyse MLN tissue from a murine model of S. Typhimurium infection.
159  subsequent phosphorylation in response to S Typhimurium infection.
160 entified to contribute to this step of the S Typhimurium infectious cycle.
161 y Salmonella enterica serovar Typhimurium (S Typhimurium) inhibits T cell responses and mediates viru
162 port that an intestinal pathogen, Salmonella Typhimurium, inhibits anorexia by manipulating the gut-b
163 ted with PBA exhibited significantly lower S Typhimurium intestinal colonization and dissemination to
164  standard DNA and 10(1) copies of Salmonella typhimurium InvA gene sequences (cloned in E. coli and a
165                                        An S. Typhimurium invA mutant defective in the Salmonella path
166 inactivated the SPI-1 T3SS and attenuated S. Typhimurium invasion.
167                  Salmonella enterica serovar Typhimurium is a common cause of food-borne gastrointest
168                 Salmonella enterica serotype Typhimurium is a food-borne pathogen that also selective
169                                   Salmonella typhimurium is a major cause of diarrhea and causes sign
170 ne resistance of Salmonella enterica serovar Typhimurium is attributed to the high-molecular-weight L
171                 We demonstrate that while S. Typhimurium is equally invasive under both aerobic and m
172 lls, in which growth of cytosolic Salmonella Typhimurium is inhibited independently or prior to the o
173                                   Salmonella typhimurium is responsible for about a third of all case
174 ism of FrmR from Salmonella enterica serovar Typhimurium is triggered by metals in vitro, and variant
175                                              Typhimurium is unclear, although as IgG2a is induced by
176 gative bacterium, Salmonella Typhimurium (S. Typhimurium) is a food borne pathogen responsible for nu
177 s between this lineage and other non-iNTS S. Typhimurium isolates is the presence of prophage BTP1.
178  resistance was noted in 12.7% of Salmonella Typhimurium isolates, appearing in Bas-Congo from 2013 o
179 ease SPI-6 antibacterial activity and that S Typhimurium kills commensal bacteria in a T6SS-dependent
180 ined that, in a murine model of infection, S Typhimurium lacking both l-asparaginase I and II genes c
181 t in the closely related S. enterica serovar Typhimurium LT2 and from a mutant of S Montevideo, each
182           We recode 200 kb of the Salmonella typhimurium LT2 genome through a process we term SIRCAS
183 E. coli O157:H7, Salmonella enterica serovar Typhimurium LT2, Staphylococcus aureus, and Streptococcu
184               In Salmonella enterica serovar Typhimurium, Mg(2+) limitation induces transcription of
185           Following oral inoculation with S. Typhimurium, mice develop a hematopathological syndrome
186 lly found on the Salmonella enetrica serovar Typhimurium multi-resistance plasmid pMG101 from burns p
187 racellular infectious cycle, we screened a S Typhimurium multigene deletion library in Caco-2 C2Bbe1
188 , but avirulent, Salmonella enterica serovar Typhimurium mutant for its ability to compete with wild-
189                                        An S. Typhimurium mutant strain lacking these two effectors ex
190      In this study, a flagellin-deficient S. Typhimurium mutant was constructed.
191                                              Typhimurium mutants as surrogates for expression of tran
192                          A library of 182 S. Typhimurium mutants each containing a targeted deletion
193 nvestigate the impact of coupling Salmonella typhimurium O-antigen to different amino acids of CRM197
194 actericidal activity can be influenced by S. Typhimurium OAg strain, most likely as a result of diffe
195 is study was to investigate the effect of S. typhimurium on inflammasomes in primary human monocytes.
196 led Nlrc4(-/-) BMDMs in their response to S. typhimurium or flagellin.
197 y IgY from chickens infected with Salmonella Typhimurium or S.
198 against 10,000 50% lethal doses (LD50) of S. Typhimurium or S. Enteritidis, respectively.
199                                   Salmonella typhimurium or Toxoplasma gondii were administered to kn
200 LRC4 in macrophages infected with Salmonella typhimurium or transfected with flagellin.
201  coli (EHEC) and Salmonella enterica serovar Typhimurium, or the surrogate murine infection model for
202  with IBS, larger numbers of E coli HS and S typhimurium passed through the epithelium than in biopsi
203 the prototypical Salmonella enterica serovar Typhimurium pathogenicity island 1 basal body, determine
204 oid from Scutellaria baicalensis, targets S. Typhimurium pathogenicity island-1 (SPI-1) type III secr
205 rug resistant, whereas a dominant Salmonella Typhimurium pathotype, ST313, was primarily associated w
206 deficient CX3CR1(-/-) mice the numbers of S. Typhimurium penetrating the epithelium were significantl
207                                              Typhimurium penetrating the epithelium were significantl
208                                              Typhimurium porins including outer membrane protein OmpD
209 ce IgG1, whereas Th1 Ags, such as Salmonella Typhimurium, predominantly induce IgG2a.
210                    Upon entering the host, S Typhimurium preferentially colonizes Peyer's patches, a
211 a detection limit of 10(2) CFU mL(-1) for S. typhimurium, providing an instrument-free quantitative a
212 scherichia coli, Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Bacillus subtilis,
213  in nontyphoidal Salmonella enterica serovar Typhimurium reduced flagellin-induced pyroptosis.
214                                              Typhimurium, reducing virulence while increasing transmi
215  4.8; 95% CI, 1.1-21.1; P = .039).Salmonella Typhimurium represented 106 of 238 (44.5%) serotyped iso
216 ogenic bacterium Salmonella enterica serovar Typhimurium requires a T6SS encoded within Salmonella pa
217 1) for Staphylococcus aureus, and Salmonella typhimurium, respectively.
218 e II produced by Salmonella enterica serovar Typhimurium (S Typhimurium) inhibits T cell responses an
219 o infection with Salmonella enterica serovar Typhimurium (S Typhimurium).
220                  Salmonella enterica serovar Typhimurium (S.
221 onocytogenes and Salmonella enterica serovar Typhimurium (S.
222 dent exposures to flagellins from Salmonella typhimurium (S. typhimurium) and Bacillus subtilis (B. s
223      The Gram-negative bacterium, Salmonella Typhimurium (S. Typhimurium) is a food borne pathogen re
224                           In contrast, the S Typhimurium sapA mutants had similar sensitivity to osmo
225      Salmonella (Salmonella enterica serovar Typhimurium) secrete numerous effector proteins, includi
226  antigen extraction was done from Salmonella typhimurium serovars, under the optimized growth conditi
227       Flagellin isolated from the Salmonella Typhimurium SJW1660 strain, which differs by a point mut
228 generated defined mutant derivatives using S Typhimurium SL1344 as the host.
229 sitive immunosensor for detecting Salmonella typhimurium species.
230  we show that infection of host cells with S Typhimurium specifically induces the ubiquitination of t
231   Weight loss, serum cytokine levels, and S. typhimurium splenic translocation were measured.
232 e catalytic triad, is variable, with serovar Typhimurium SpvD having an arginine and serovar Enteriti
233  by a ubiquitin-binding domain in Salmonella Typhimurium SseL.
234 ections of Gram-negative Salmonella enterica Typhimurium (ST), a major source of human food poisoning
235            The B cell response to Salmonella typhimurium (STm) occurs massively at extrafollicular si
236 abbits were orally infected with S. enterica Typhimurium strain chi3987 harboring phagemid NgoPhi6 fm
237 d in vivo killing of the invasive African S. Typhimurium strain D23580.
238 nomes of S. enterica subsp. enterica serovar Typhimurium strain LT2 and Salmonella bongori strain 124
239 tuberculosis, in Salmonella enterica serovar Typhimurium strain SL3261.
240  not affect Ab responses to a noninvasive S. Typhimurium strain that specifically targeted the CX3CR1
241                                              Typhimurium strain that specifically targeted the CX3CR1
242 ture of metabolically competitive Salmonella typhimurium strains in microfluidic devices.
243                                              Typhimurium succinate utilization genes contribute to ef
244 ne secretion by S. Paratyphi A but not by S. Typhimurium, suggesting that SPI-1 expression is natural
245                                              Typhimurium survival mechanisms in macrophages, and can
246 r results reveal a novel strategy in which S Typhimurium T3SS effectors broaden their functions throu
247 w that human NAIP also senses the Salmonella Typhimurium T3SS inner rod protein PrgJ and that T3SS in
248 rene, an indirect mutagen, toward Salmonella typhimurium TA 98 and TA 100.
249  (4-NQO), a direct mutagen toward Salmonella typhimurium TA 98 and TA 100.
250 induced mutagenicity (26%) in the Salmonella typhimurium TA102 strain, as determined by the Ames test
251 genic effect by Ames test against Salmonella typhimurium TA98 and TA100 strains.
252 the highest antimutagenic activity toward S. typhimurium TA98 and TA100.
253  more susceptible to systemic infection by S Typhimurium than wild-type mice.
254 activity against Salmonella enterica serovar Typhimurium that is not shared by the related purine met
255 y labeled Escherichia coli HS and Salmonella typhimurium that passed through from the mucosal side to
256  together with l-asparaginase I to provide S Typhimurium the ability to catabolize asparagine and ass
257 genes, Pseudomonas aeruginosa and Salmonella Typhimurium The geranylated residues are located in the
258  tested for efficacy only against Salmonella Typhimurium, the modified Salmonella strain may be able
259 ions, strains of Salmonella enterica serovar Typhimurium, the murine model of S Typhi, in which vario
260 ne expression during infection by Salmonella typhimurium This occurred in the first 3 d of infection,
261                                              Typhimurium tissue colonization and consequently disease
262  the response of Salmonella enterica serovar Typhimurium to diverse environmental challenges encounte
263  isotypes specific for the O:4 antigen of S. Typhimurium to effect in vitro and in vivo killing of th
264                                              Typhimurium to H2O2L and H2O2H, and the results were val
265 ing transposon insertion mutant library of S Typhimurium to immune serum identified a repertoire of S
266 d the ability of Salmonella enterica serovar Typhimurium to infect the central nervous system and cau
267 amily members of Salmonella enterica serovar Typhimurium to link the constitutively expressed CspC an
268 briae (Lpf), which facilitate adherence of S Typhimurium to M cells.
269       Thus, manganese acquisition enables S. Typhimurium to overcome host antimicrobial defenses and
270 In order to assess the ability of Salmonella Typhimurium to replicate in human macrophages, we infect
271                                              Typhimurium to utilize a variety of carbon sources, incl
272            We observed that the number of S. Typhimurium traversing the epithelium did not differ bet
273                                              Typhimurium traversing the epithelium did not differ bet
274 ntracellular pathogens, including Salmonella typhimurium, trigger autophagy in host cells, which is w
275 e killing of Escherichia coli and Salmonella typhimurium, two common pathogens, at levels 10- to 20-t
276 solution in situ structure of the Salmonella Typhimurium type III secretion machine obtained by high-
277                                              Typhimurium undergoes an incomplete tricarboxylic acid (
278 estinal pathogen Salmonella enterica serovar Typhimurium uses specialized metal transporters to evade
279                                To pinpoint S Typhimurium virulence factors responsible for these step
280  that asparagine catabolism contributes to S Typhimurium virulence, providing new insights into the c
281   Infection of DR3(-/-) mice with Salmonella typhimurium was associated with defective microbial clea
282 ng this system, the limit of detection of S. typhimurium was found to be 10(2) CFU mL(-1) in culturin
283                                   Salmonella Typhimurium was infrequent (2.3% pups; 4/175), mostly si
284 ly infected with Salmonella enterica serovar Typhimurium was investigated.
285 ver, in these mice the number of invading S. Typhimurium was significantly reduced after the adoptive
286                                              Typhimurium was significantly reduced after the adoptive
287 ein secretion in Salmonella enterica serovar Typhimurium, we discovered that several TCMs can attenua
288                                              Typhimurium, we found that ArtB binds human glycans, ter
289 of designing an effective vaccine against S. Typhimurium, we have synthesized different glycoconjugat
290                 Here, by studying Salmonella Typhimurium, we show that the E3 ligase LUBAC generates
291 hin 1 hour, greater numbers of T gondii or S typhimurium were present within mucosae of mice with mig
292 d protection against infection by Salmonella typhimurium were spared.
293 cytogenes V7 and Salmonella enterica serovar Typhimurium were used as model pathogens to evaluate the
294 nse to the intracellular pathogen Salmonella typhimurium, which can disrupt metabolism by uptake of h
295 he phagosome mediates host defense against S Typhimurium, which is counteracted by copper export from
296  available experimental data from Salmonella typhimurium with only a single free parameter.
297  a direct label-free detection of Salmonella Typhimurium with the limit of detection (LOD) of 10(4) C
298  used to capture a food pathogen, Salmonella typhimurium, with starting concentrations as low as 10(
299 od was confirmed to be highly specific to S. typhimurium without interference from other pathogenic b
300                                        The S Typhimurium yfgA mutant lost the characteristic Salmonel

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top